AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants

The novel coronavirus SARS-CoV-2 and the associated infectious disease COVID-19 pose a significant challenge to healthcare systems worldwide. Patients with cancer have been identified as a high-risk population for severe infections, rendering prophylaxis and treatment strategies for these patients p...

Descripción completa

Detalles Bibliográficos
Autores principales: Giesen, Nicola, Busch, Elena, Schalk, Enrico, Beutel, Gernot, Rüthrich, Maria M., Hentrich, Marcus, Hertenstein, Bernd, Hirsch, Hans H., Karthaus, Meinolf, Khodamoradi, Yascha, Koehler, Philipp, Krüger, William, Koldehoff, Michael, Krause, Robert, Mellinghoff, Sibylle C., Penack, Olaf, Sandherr, Michael, Seggewiss-Bernhardt, Ruth, Spiekermann, Karsten, Sprute, Rosanne, Stemler, Jannik, Weissinger, Florian, Wörmann, Bernhard, Wolf, Hans-Heinrich, Cornely, Oliver A., Rieger, Christina T., von Lilienfeld-Toal, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737523/
https://www.ncbi.nlm.nih.gov/pubmed/36652889
http://dx.doi.org/10.1016/j.ejca.2022.11.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737523/
https://www.ncbi.nlm.nih.gov/pubmed/36652889
http://dx.doi.org/10.1016/j.ejca.2022.11.030

Ejemplares similares